Curex offers physician-supervised sublingual immunotherapy (SLIT) delivered at home: custom daily allergen drops, remote dose adjustments, and a supervised oral food challenge at a partner center, for a monthly fee.
Sublingual immunotherapy (SLIT) uses daily drops under the tongue, held for two minutes, to retrain the immune system and raise tolerance to specific food allergens.
Curex provides custom-formulated drops, regular video check-ins with an allergist, and arranges a medically supervised oral food challenge at a Center of Excellence.
The program is offered for adults and children as young as 2, costs $199 per month, and reports an 87% completion rate compared with fewer than 30% for many in-clinic oral immunotherapy programs.
Why families consider alternatives to strict avoidance
Living with a food allergy often means strict avoidance and constant vigilance. Avoidance prevents exposure but leaves the body's reaction threshold unchanged, so accidental contact can still cause severe reactions.
Sublingual immunotherapy (SLIT) delivers small, daily doses of the allergen as drops placed under the tongue. The drops are held for two minutes before swallowing. Over time, the allergist increases the dose to help the immune system build tolerance. The stated goal is to reach a level of protection that allows patients to pass a medically supervised oral food challenge.
Curex's Food Allergy Program adapts the SLIT approach to an at-home model with physician oversight. Key operational features described in the article:
The article states a subscription price of $199 per month, which covers the custom drops, physician oversight, and the supervised oral food challenge. Curex reports treating over 50,000 patients. The company claims an 87% treatment completion rate, compared with under 30% completion for many in-clinic OIT programs. The piece frames the lower cost and remote format as reasons more families can start and finish treatment.
Patient and clinician perspectives included in the piece
A quoted clinician, Dr. Chet Tharpe, MD, framed the program as a way to deliver gradual, physician-supervised treatment without requiring families to disrupt their lives for travel or repeated clinic visits.
Several patient testimonies are provided: one parent, Jenna W., described passing a supervised food challenge after three years and enjoying routine activities like pizza night without fear. Other brief member quotes cover outcomes for peanut, shellfish, cow's milk, and multiple allergies.
The article presents a call to action: a free online quiz to determine eligibility and a promotional enrollment discount mentioned in the original piece. The core steps implied are allergy testing, enrollment for tailored drops and remote supervision, daily at-home dosing, routine video check-ins, and a supervised oral food challenge arranged through the program.
For families seeking an alternative to strict avoidance or costly, travel-intensive clinic programs, Curex positions its home-based SLIT model as a lower-cost, more convenient route to build measurable tolerance. The program is presented as supervised medicine rather than a do-it-yourself approach, with physician oversight and a structured path to an oral food challenge.
Details to confirm with a clinician
Before starting any immunotherapy, families should confirm whether SLIT fits their child's medical profile, discuss safety and emergency planning, and verify the credentials and oversight model of any program. The article presents Curex's claims and patient stories as the basis for considering this option.
For someone with a serious peanut allergy, a few crumbs can turn an ordinary meal into a medical emergency. Researchers are now exploring a surprising place to change that response: the trillions of microbes living in the gut. In a small early-stage clinical trial, 15 people with peanut allergy swallowed capsules conta
Denise Woodard remembers standing in her home kitchen in 2019, already thinking big. “We had one other employee, and I was like, ‘We’re going to make a Girl Scout cookie one day,’” she recalls. “I think she thought I had lost the plot!” But Woodard was right. As a dietitian and food-allergy parent, I know first-hand th
A figleaf gourd enzyme significantly reduced peanut allergen immunoreactivity, but researchers caution the treated proteins are not yet allergy-safe. The post Enzyme from Pumpkin Relative Helps Reduce Peanut Allergenicity appeared first on SnackSafely.com .
Dupilumab dramatically lowers food-specific IgE, but new research finds those declines may not signal increased food tolerance. The post Study Finds Eczema Drug Dupilumab Drives Down Food Allergy IgE but Increases Reactions appeared first on SnackSafely.com .
NIH researchers discovered rare antibodies that could potentially block allergic reactions in people with alpha-gal syndrome. The post Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome appeared first on SnackSafely.com .
![[Sponsored] IP8 Expands into Patent Decision Intelligence with Five Connected AI Workflows](/api/proxy/image?url=https%3A%2F%2Fi0.wp.com%2Fspicyip.com%2Fwp-content%2Fuploads%2F2026%2F09%2FPatseer-IP8-Sponsored-14-sept.png%3Ffit%3D1200%252C628%26ssl%3D1)
A year after launching agentic AI for patent-infringement surveillance, IP8 expands across critical patent decision workflows for law firms and enterprise IP teams. To know more, read their press release below:- [Sponsored] IP8 Expands into Patent Decision Intelligence with Five Connected AI Workflows (13 September 202
Loading more related stories...
Open the app view to save this story, compare related coverage, and continue from the same source.